Stability Study of Isoniazid and Rifampicin Oral Solutions Using Hydroxypropyl-Β-Cyclodextrin to Treat Tuberculosis in Paediatrics

(1) Background: First-line antituberculosis treatment in paediatrics entails the administration of Isoniazid, Pyrazinamide, and Rifampicin. This study examines the possibility of developing a combined dose liquid formulation for oral use that would facilitate dose adjustment and adherence to treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Santoveña-Estévez, Ana, Suárez-González, Javier, Cáceres-Pérez, Amor R., Ruiz-Noda, Zuleima, Machado-Rodríguez, Sara, Echezarreta, Magdalena, Soriano, Mabel, Fariña, José B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076452/
https://www.ncbi.nlm.nih.gov/pubmed/32102447
http://dx.doi.org/10.3390/pharmaceutics12020195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076452/
https://www.ncbi.nlm.nih.gov/pubmed/32102447
http://dx.doi.org/10.3390/pharmaceutics12020195

Ejemplares similares